Table A13.

Van Der Star 2022 [43].

Methods	Type of study: Interventional study Study design: Retrospective case series with prospectively collected data
Participants	Country: the Netherlands Number of individuals with keratoconus: 29 Number of eyes: 35 Subgroups: preoperative Kmax > 69D (group 1), preoperative Kmax < 69D (group 2), 1 month postoperative, 1 year postoperative, last available follow-up Inclusion criteria: keratoconus progression (Kmean ≥ 1D Δ ± Kmax ≥ 2D Δ), keratoconus stage II-IV Exclusion criteria: -
Interventions	Donor tissue: epithelial removal, superficial incision, lifting and grasping BL edge (McPherson forceps/custom-made tying forceps), peeling Bowman layer (30G needle), ethanol 70%, organ culture medium (CorneaMax) Surgical technique: air in anterior chamber, mid-stromal pocket, ethanol 70%, BSS, trypan blue 0.06%, Bowman layer placement on the glide (BD Visitec Surgical Glide), graft insertion into stromal pocket Graft size: 9–11 mm Postoperative medication: chloramphenicol eye drops 0.5% 6x/day (1 month), dexamethasone eye drops 0.1% 4x/day (1 month), followed by FML 0.1% 4x/day, tapered to 1x/day over a period of 1 year
Outcomes	BSCVA (logMAR), BCLVA (logMAR), Kmax (D), Kmean (D), TPT (μm), CCT (μm), complications, success rate